<head>
    <!-- Stylesheet -->
    <link rel="stylesheet" href="css/dosing.css">
</head>
<!-- Main -->
<main>
    <div class="tabs">
        <a href="" ui-sref="DOSING" class="tab">DOSING</a>
        <a href="" ui-sref="DOSE-MODIFICATIONS" class="tab">DOSE MODIFICATIONS</a>
        <a href="" ui-sref="STORAGE-AND-HANDLING" class="tab tab--active">STORAGE &amp; HANDLING</a>
    </div>

    <h2 class="primary">How Supplied/Storage and Handling<sup>1</sup></h2>
    
    <h3 class="secondary-variant">How supplied</h3>
    <section class="storage-figure">
        <div class="figure-data">
            <img src="assets/svg/dosing/vial.svg" alt="Vial Illustration" />
            <ul>
                <li>
                    <h4 class="light"> BELEODAQ is supplied in single-vial cartons; each <span class="secondary-variant2 semibold">30 mL clear vial</span> contains sterile, lyophilized powder equivalent to 500 mg of belinostat</h4>
                </li>
                <li>
                    <h4 class="light">NDC 68152-108-09: individual carton of BELEODAQ <span class="secondary-variant2 semibold">30 mL single-dose vial</span> containing 500 mg of belinostat</h4>
                </li>
            </ul>
        </div>
    </section>
    <h3 class="secondary-variant">Storage and handling</h3>
    <section class="storage-figure">
        <div class="figure-data">
            <img src="assets/svg/dosing/thermometer.svg" alt="Thermometer Illustration" />
            <ul>
                <li>
                    <h4 class="light">Store BELEODAQ at <span class="secondary-variant2 semibold">room temperature 20&deg;C to 25&deg;C</span> (68&deg;F to 77&deg;F)</h4>
                </li>
                <li>
                    <h4 class="light">Excursions are permitted between <span class="secondary-variant2 semibold">15&deg;C and 30&deg;C</span> (59&deg;F and 86&deg;F). Retain BELEODAQ in its <span class="secondary-variant2 semibold">original packaging</span> until ready for use (see US Pharmacopeia [USP] controlled room temperature)</h4>
                </li>
                <li>
                    <h4 class="light">BELEODAQ is a cytotoxic drug. Follow special handling and disposal procedures</h4>
                </li>
            </ul>
        </div>
    </section>

    <h2 class="primary">Reconstitution and Infusion Instructions<sup>1</sup></h2>
    <div class="instructions">
        <img src="assets/svg/dosing/12hours.svg" alt="12 hour stopwatch" />
        <ul>
            <li>
                <h4 class="light">Aseptically reconstitute <span class="primary semibold">each vial of BELEODAQ</span> by adding 9 mL of sterile water for injection, USP, into the BELEODAQ vial with a suitable syringe to achieve <span class="primary semibold">a concentration of 50 mg</span> of belinostat per mL</h4>
            </li>
            <li>
                <h4 class="light">
                    Swirl the contents of the vial until there are <span class="primary semibold">no visible particles</span> in the resulting solution
                </h4>
            </li>
            <li>
                <h4 class="light">
                    The reconstituted product may be <span class="primary semibold">stored for up to 12 hours</span> at ambient temperature (15&deg;C to 25&deg;C; 59&deg;F to 77&deg;F)
                </h4>
            </li>
        </ul>
    </div>
    <div class="instructions reverse">
        <ul>
            <li>
                <h4 class="light">Aseptically <span class="secondary semibold">withdraw the volume needed</span> for the required dosage (based on the 50 mg/mL concentration and the patient’s BSA (m<sup>2</sup>) and <span class="secondary semibold">transfer to an infusion bag</span> containing 250 mL of 0.9% sodium chloride injection</h4>
            </li>
            <li>
                <h4 class="light">The infusion bag with drug solution may be stored at ambient room temperature (15&deg;C to 25&deg;C; 59&deg;F to 77&deg;F) for <span class="secondary semibold">up to 36 hours</span>, including infusion time</h4>
            </li>
        </ul>
        <img src="assets/svg/dosing/secondary-iv.svg" alt="blue iv bag" />
    </div>
    <div class="instruction-items">
        <div class="instruction-item">
            <h4 class="light">Visually <span class="tertiary semibold">inspect the solution for particulate matter</span>. Do not use if cloudiness or particulates are observed
            </h4>
            <img src="assets/svg/dosing/matter.svg" alt="orange matter particles" />
        </div>
        <div class="instruction-item">
            <img src="assets/svg/dosing/tertiary-iv.svg" alt="orange iv bag" />
            <h4 class="light">Connect the <span class="tertiary semibold">infusion bag</span> containing the drug solution to an <span class="tertiary semibold">infusion set</span> with a 0.22 μm inline filter for administration
            </h4>
        </div>
        <div class="instruction-item">
            <h4 class="light">Infuse IV over <span class="tertiary semibold">30 minutes</span>. If infusion site pain or other symptoms potentially attributable to the infusion occur, the <span class="tertiary semibold">infusion time may be extended to 45 minutes</span></h4>
            <img src="assets/svg/dosing/tertiary-watch.svg" alt="orange stop watch" />
        </div>
    </div>
    <p class="light">BSA, body surface area; IV, intravenously.</p>
    <div class="button-group">
        <a href="" ui-sref="SAFETY" class="button secondary"><i class="fas fa-chevron-left"></i> Safety &amp; Tolerability</a>
        <a href="" ui-sref="ACCESS" class="button">Access &amp; Resources <i class="fas fa-chevron-right"></i></a>
    </div>
</main>